Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease-Reference-Cited by-同舟云学术

Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease

Published:2019-03-04 Issue:5 Volume:85 Page:935-948
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Sheetz Matthew¹,Barrington Philip²,Callies Sophie³,Berg Paul H.¹,McColm Juliet²,Marbury Thomas⁴,Decker Brian⁵,Dyas Gregory L.¹,Truhlar Stephanie M.E.⁶,Benschop Robert¹,Leung Donmienne⁶,Berg Jolene⁷,Witcher Derrick R.¹^ORCID

Affiliation:

1. Eli Lilly and Company Indianapolis Indiana USA

2. Eli Lilly and Company Windlesham Surrey UK

3. Eli Lilly and Company Paris France

4. Orlando Clinical Research Center Orlando Florida USA

5. Indiana University School of Medicine Indianapolis Indiana USA

6. Eli Lilly and Company San Diego California USA

7. DaVita Clinical Research Minneapolis Minnesota USA

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13877

Reference51 articles.

1. Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease

2. Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

3. Mechanism of Increased Mortality Risk with Erythropoietin Treatment to Higher Hemoglobin Targets

4. Current and future chemical therapies for treating anaemia in chronic kidney disease

5. Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia of inflammation and iron metabolism in chronic diseases;Revista Clínica Española (English Edition);2024-09

2. Anemia de la inflamación y metabolismo del hierro en las enfermedades crónicas;Revista Clínica Española;2024-09

3. Absolute and functional iron deficiency: Biomarkers, impact on immune system, and therapy;Blood Reviews;2024-08

4. Renal anemia: from relative insufficiency of EPO to imbalance of erythropoiesis and eryptosis;International Urology and Nephrology;2024-07-09

5. Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI);Advances in Therapy;2024-01-27